Indian manufacturers seek tariff review on medical devices

Medical device manufacturers in India are urging the government to reconsider tariffs on imported medical devices. They express concern over the potential reduction of import duties as the government explores trade agreements, especially with the US. The Association of Indian Medical Device Industry (AiMeD) highlights that tariffs on medical devices in India are already among the lowest in the world. They caution that further cuts could harm local manufacturers. Rajiv Nath, a spokesperson for AiMeD, emphasizes the importance of maintaining existing tariffs to bolster healthcare security in India. Currently, India applies basic customs duties ranging from 0% to 7.5% on imported medical devices, with many products from the US facing zero duties. The AiMeD notes that US manufacturers hold a significant market share in India. They call for a balanced approach that considers both tariff and non-tariff barriers, which can affect product access in the market. Manufacturers point out that non-tariff barriers, such as high FDA registration fees and costs associated with clinical trials in the US, create challenges for Indian companies. They urge the government to negotiate fair trade terms that include consistent tariff measures with the US. The manufacturers also reference global examples, like tariffs on syringes and needles imposed by the US. They suggest India could introduce similar tariffs to protect its medical device sector and prepare for future health crises. In conclusion, the AiMeD argues that India should focus on strengthening its medical device industry. They believe a strategic balance in tariff policies will help secure India’s healthcare needs and enhance its global competitiveness in the medical device market.